Usefulness of vasculitis biomarkers in the era of the personalized medicine
- 1 May 2020
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 19 (5), 102514
- https://doi.org/10.1016/j.autrev.2020.102514
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitisAnnals Of The Rheumatic Diseases, 2013
- Understanding the Pathogenesis of Kawasaki Disease by Network and Pathway AnalysisComputational and Mathematical Methods in Medicine, 2013
- Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysisAnnals Of The Rheumatic Diseases, 2012
- Anti-Neutrophil Cytoplasmic Antibodies Stimulate Release of Neutrophil MicroparticlesJournal of the American Society of Nephrology, 2012
- Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysisRheumatology, 2011
- Serum HMGB1 levels are increased in active Wegener's granulomatosis and differentiate between active forms of ANCA-associated vasculitisAnnals Of The Rheumatic Diseases, 2010
- EULAR recommendations for the management of primary small and medium vessel vasculitisAnnals Of The Rheumatic Diseases, 2008
- Factor XIII in Henoch‐Schönlein purpura with isolated gastrointestinal symptomsPediatrics International, 2006
- Diagnostic significance of ANCA in vasculitisNature Clinical Practice Rheumatology, 2006
- Renal histology in ANCA-associated vasculitis: Differences between diagnostic and serologic subgroupsKidney International, 2002